Unternehmen Albert Labs International Corp. OTC Markets
Aktien
A3DJEF
CA0127841041
ALBLF
Biotechnologie
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
- USD | -.--% |
|
-.--% | -.--% |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | 61 | - | |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Graeme McFarlane
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Ravinder Kang
BRD | Director/Board Member | 58 | - |
Mike Thompson
BRD | Director/Board Member | - | 11.07.22 |
Richard Skaife
BRD | Director/Board Member | - | - |
Frank J. Lane
BRD | Director/Board Member | 57 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Director/Board Member | - | 11.07.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 74 413 267 | 63 035 215 ( 84,71 %) | 0 | 84,71 % |
Unternehmenskontakt
Albert Labs International Corp.
6996, Merritt Avenue
V5J 4R6, Burnaby
+778-819-0740
http://www.albertlabs.com![Straße Albert Labs International Corp.(ALBLF)](https://cdn.zonebourse.com/static/address/166577859.png)
Sektor
Umsatz je Region
% 1. Jan. | Kap. | |
---|---|---|
+19.41% | 45.51 Mrd. | |
-8.62% | 38.52 Mrd. | |
+38.68% | 38.13 Mrd. | |
+26.95% | 30.74 Mrd. | |
-13.50% | 26.03 Mrd. | |
+10.74% | 25.92 Mrd. | |
+44.87% | 14.13 Mrd. | |
+34.36% | 12.73 Mrd. | |
-7.14% | 11.29 Mrd. |
- Börse
- Aktien
- ABRT Aktie
- A3DJEF Aktie
- Unternehmen Albert Labs International Corp.